首页> 美国卫生研究院文献>The Open Orthopaedics Journal >The Effectiveness of Corticosteroid Injection for De Quervain’s Stenosing Tenosynovitis (DQST): A Systematic Review and Meta-Analysis
【2h】

The Effectiveness of Corticosteroid Injection for De Quervain’s Stenosing Tenosynovitis (DQST): A Systematic Review and Meta-Analysis

机译:皮质类固醇注射液对De Quervain狭窄性腱鞘炎(DQST)的有效性:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

De Quervain’s stenosing tenosynovitis (DQST) treatments include corticosteroid injection around the tendon sheath; however there is some ambiguity concerning the efficacy of this treatment. The aim of this systematic review and meta-analysis is to examine the totality of evidence relating to the use of corticosteroid injection in DQST when compared to placebo or other active treatments. A systematic literature search was conducted in July 2014. Only randomized control trials (RCTs) were included. Outcome measures included impairment, activity limitation and participation restriction. Five RCTs were identified with 165 patients, 88 in the treatment group and 77 in the control group.Patients who received corticosteroid injection (n=142) had a higher rate of resolution of symptoms [RR 2.59, 95% CI: 1.25 to 5.37, p=0.05, I2=62%]. This group reported greater pain relief as assessed by Visual Analogue Scale (VAS) at first assessment [mean difference -2.51, 95% CI: -3.11 to -1.90, p=0.0003, I2=65%] and demonstrated a statistically significant improvement in function (n=78) as measured by the DASH score and Dutch AIMS-HFF score [SMD -0.83, 95% CI: -1.54 to -0.12, p=0.02, I2=48]. This review confirms that corticosteroid injection results in a statistically significant increase in resolution of symptoms, pain relief and increased function in the treatment of DQST.
机译:De Quervain的狭窄性腱鞘炎(DQST)治疗包括在腱鞘周围注射皮质类固醇;然而,这种治疗方法的有效性存在一些歧义。该系统评价和荟萃分析的目的是,与安慰剂或其他有效治疗方法相比,检查与在DQST中使用皮质类固醇注射剂有关的全部证据。 2014年7月进行了系统的文献检索。仅包括随机对照试验(RCT)。结果指标包括损害,活动限制和参与限制。共有165例患者接受了5项随机对照试验,治疗组88例,对照组77例。接受皮质类固醇注射(n = 142)的患者症状缓解率更高[RR 2.59,95%CI:1.25至5.37, p = 0.05,I 2 = 62%]。该组在初次评估时通过视觉模拟量表(VAS)评估了更大的疼痛缓解[平均差异-2.51,95%CI:-3.11至-1.90,p = 0.0003,I 2 = 65% ],并通过DASH评分和荷兰AIMS-HFF评分[SMD -0.83,95%CI:-1.54至-0.12,p = 0.02,I 2],显示出功能上的统计学显着改善(n = 78) = 48]。这项审查证实,皮质类固醇注射剂可导致DQST的症状缓解,疼痛缓解和功能增强在统计学上显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号